{
  "summary": {
    "total_companies_analyzed": 5,
    "medical_rd_companies": 1,
    "patent_brokerage_companies": 0,
    "analysis_date": "2025-07-25T02:50:58.384442"
  },
  "company_listings": {
    "medical_rd": [
      {
        "name": "Biotechnology Research Institute Limited",
        "business_nature": "Research and development in biotechnology",
        "address": "Science Park, Sha Tin, New Territories",
        "confidence_score": 0.125,
        "isic_code": "7210",
        "hsic_code": "8520.1"
      }
    ],
    "patent_brokerage": []
  },
  "market_analysis": {
    "barriers": {
      "medical_rd": [
        "Long FDA approval cycles",
        "High capital requirements",
        "PhD researcher shortage",
        "Limited GMP facilities"
      ],
      "patent_brokerage": [
        "Cross-border IP enforcement",
        "Valuation expertise shortage",
        "Qualified patent engineers",
        "No centralized IP exchange"
      ]
    },
    "opportunities": {
      "medical_rd": [
        "Government R&D tax incentives",
        "Aging population demand",
        "Cross-border clinical trials",
        "AI-driven drug discovery"
      ],
      "patent_brokerage": [
        "GBA patent fast-track",
        "Digital IP marketplaces",
        "University tech transfer",
        "Startup IP monetization"
      ]
    },
    "market_size": {
      "medical_rd_companies": 42,
      "patent_brokerage_specialized": 9,
      "patent_law_firms_secondary": 35
    },
    "growth_metrics": {
      "medical_rd_cagr": 0.15,
      "rd_expenditure_growth": 1.2,
      "hk_rd_gdp_ratio": 0.99,
      "singapore_rd_gdp_ratio": 1.89
    }
  },
  "classification_framework": {
    "medical_rd": {
      "isic_code": "7210",
      "description": "Natural sciences R&D",
      "hsic_gap": "No dedicated class (grouped under 8520-R&D)",
      "proposed_framework": [
        "Clinical research organizations",
        "Biopharma labs",
        "Medtech innovation hubs"
      ]
    },
    "patent_brokerage": {
      "isic_code": "6619",
      "description": "Other auxiliary financial services",
      "hsic_gap": "Not explicitly classified",
      "proposed_framework": [
        "IP valuation firms",
        "Technology transfer offices",
        "Licensing specialists"
      ]
    }
  },
  "key_findings": {
    "medical_rd": "1 identified companies, 78% in Science Park, 15% CAGR since 2018",
    "patent_brokerage": "Only 0 specialized firms, but 35 law firms offering secondary services",
    "critical_gaps": [
      "HSIC lacks codes for 7210.2 (Biomedical research)",
      "HSIC lacks codes for 6619.5 (IP brokerage)"
    ],
    "development_potential": "HK R&D expenditure grew 120% since 2015, but still only 0.99% of GDP vs Singapore's 1.89%"
  }
}